💛 A quick favor, if you've got a second.
We're really happy that you chose to read one of our stories and sincerely hope you'll stick around to read more. We took our paywall down — for now — but that won't last forever, and when the gate goes back up, we'd love for you to already be on the inside.
It's free. So please enter your email here and don't forget to like and follow us on all of your favorite Social Media platforms!

Three entertainment industry luminaries—actors Colman Domingo and Charlize Theron, along with filmmaker John Carpenter—will receive honors at the Academy Museum Gala on October 17 in Los Angeles. The prestigious annual fundraising event, marking its sixth consecutive year, has established itself as a major entertainment industry gathering on the West Coast, drawing comparisons to New York’s Met Gala.
Academy Museum Director and President Amy Homma praised the selection in a statement, noting that the honorees’ “extraordinary careers exemplify the creativity, innovation, and excellence that continues to move the industry forward.” The event’s host committee comprises Questlove, Judd Apatow, Teyana Taylor, Ludwig Göransson, Seth Rogen and Demi Moore, with co-chairs Robert Rodriguez, Steven Spielberg and Kate Capshaw.
Theron and Carpenter will participate in museum programming tied to the gala. Theron will engage in a conversation with the museum’s teen council and attend a screening of “Mad Max: Fury Road,” while Carpenter will preside over three nights of screenings featuring his films, including “Halloween,” which aligns with the museum’s new exhibition “The Horror Show.”
Last year’s gala, which honored Bruce Springsteen, Penélope Cruz, Bowen Yang and filmmaker Walter Salles, generated more than $12 million for the museum’s exhibitions and public screenings.
More Stories
Rumer Willis Relocates to Nashville, Marks Fresh Start Following Custody Agreement
Stephen A. Smith Questions Stephanie White’s Leadership Following Flagrant Foul Controversy
Chestnut Falls Short in Tater Tot Contest, But Asterisk Applies to Controversial Loss